MedPAC says 2023 hospital payments shouldn’t increase in response to COVID-19
CMS shouldn’t increase Medicare payments to hospitals for the upcoming year beyond the annual update that is based on current law, according to the Medicare Payment Advisory Commission.
Federal funding bill addresses 340B eligibility concerns but not some other points of interest for hospitals
An FY22 appropriations bill allows hospitals to remain in the 340B Drug Pricing Program if their eligibility had been adversely affected by the COVID-19 pandemic.
Healthcare pricing update: 2 experts call for greater regulation
Recent price increases have been slower in healthcare than in the economy at large, but two healthcare economists say the long-term price trends should be addressed through regulation.
Understanding the Healthcare Revenue Cycle Process
Revenue cycle management is the process used by healthcare systems to track the revenue from patients, from their initial appointment or encounter with the healthcare system to their final payment of balance. The most effective revenue cycle teams focus on price transparency, supporting equitable access to care, financial conversations with patients, documentation of care received, claim processing, and medical account resolution.
CMS’s overhaul of the Direct Contracting program draws praise from supporters of value-based payment
Value-based payment advocates see reason for optimism in CMS’s recent decision on the future of its Direct Contracting model.
News Briefs: Report finds unwillingness to get the COVID-19 vaccine drove healthcare job cuts in January
A roundup of top news for healthcare finance professionals.
Federal judge rules for providers in a case about a key component of the new surprise billing regulations
A federal judge found in favor of the Texas Medical Association in a case about the arbitration process that is being implemented as part of the No Surprises Act.
For some 340B hospitals, the COVID-19 pandemic has brought an unanticipated and unwelcome loss of eligibility
Bringing longer stays and higher rates of deferred care, the COVID-19 pandemic is adversely affecting 340B eligibility for some hospitals.
Medicare’s much-hyped Direct Contracting model faces an uncertain future
Medicare’s Direct Contracting model, touted as representing the evolution of alternative payment models, could be shelved less than a year after getting started.
Senate panel discusses ways to address Medicare financing — and the consequences of not acting
Medicare Part D and Medicare Advantage could be prime targets as Congress seeks to shore up the Hospital Insurance Trust Fund before it becomes insolvent in 2026 as projected.